Hain Celestial Reports Third Quarter Fiscal Year 2022 Financial Results
Total Net Sales Increased 2.1%; North America Net Sales Increased 13.3%
EPS of
Multiple Actions Being Taken to Offset Input Cost Inflation and Improve Margins
FINANCIAL HIGHLIGHTS
Summary of Third Quarter Results from Continuing Operations Compared to the Prior Year Period
- Net sales increased 2.1% to
$502.9 million compared to the prior year period. - When adjusted for foreign exchange, acquisitions, divestitures and discontinued brands, net sales increased 1.5% compared to the prior year period.
- Gross profit margin of 23.0%, a 340 basis point decrease from the prior year period.
- Adjusted gross profit margin of 23.4%, a 400 basis point decrease from the prior year period.
- Operating income of
$35.2 million compared to$49.6 million in the prior year period. - Adjusted operating income of
$42.4 million compared to$59.7 million in the prior year period. - Net income of
$24.5 million compared to$34.3 million in the prior year period. - Adjusted net income of
$29.7 million compared to$44.7 million in prior year period. - Adjusted EBITDA of
$58.7 million compared to$73.8 million in the prior year period. - Adjusted EBITDA margin of 11.7%, a 330 basis point decrease compared to the prior year period.
- Earnings per diluted share (“EPS”) of
$0.27 compared to$0.34 in the prior year period. - Adjusted EPS of
$0.33 compared to$0.44 in the prior year period. - Repurchased 3.6 million shares, or 3.8% of the outstanding common stock, at an average price of
$36.48 per share.
____________________
* Notes:
- The results contained in this press release are presented with the Tilda operating segment being treated as discontinued operations. Unless otherwise noted, all results included in this press release are from continuing operations.
- This press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. Reconciliations of non-GAAP financial measures to GAAP financial measures and other non-GAAP financial calculations are provided in the tables included in this press release.
SEGMENT HIGHLIGHTS FROM CONTINUING OPERATIONS
The Company operates under two reportable segments:
Segment gross profit in the third quarter was
Segment operating income in the third quarter was
Adjusted EBITDA in the third quarter was
International
International net sales in the third quarter were
Segment gross profit in the third quarter was
Segment operating income in the third quarter was
Adjusted EBITDA in the third quarter was
CAPITAL MANAGEMENT
As previously disclosed, the Board of Directors of the Company approved an additional
During the third quarter of fiscal year 2022, the Company repurchased 3.6 million shares, or 3.8% of the outstanding common stock, at an average price of
GUIDANCE
For the fourth quarter fiscal year 2022, compared to the prior year period, the Company expects:
- Low to mid single digit adjusted net sales growth supported by double digit growth in
North America , - Modest adjusted gross margin reduction, and
- Adjusted EBITDA down low to mid single digits (including approximately 300 basis points of foreign exchange headwind).
The Company updates its adjusted net sales and adjusted EBITDA guidance for full fiscal year 2022 compared to fiscal year 2021 and now expects:
- Approximately flat adjusted net sales,
- Modest adjusted gross margin reduction, and a
- Low double digit adjusted EBITDA decline.
Notes: Adjusted net sales is defined as adjusted for the impact of foreign currency changes, acquisitions, divestitures, and discontinued brands. All references in this “Guidance” section to growth or declines in adjusted net sales or adjusted EBITDA compared to a prior year period represent percentage growth or percentage decline.
Contacts:
Investor Relations:
ICR
hain@icrinc.com
Media:
robin@robincomm.com
Conference Call and Webcast Information
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. The words “believe,” “expect,” “anticipate,” “may,” “should,” “plan,” “intend,” “potential,” “will” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include, among other things, our beliefs or expectations relating to our future performance, results of operations and financial condition; our strategic initiatives, business strategy, supply chain, brand portfolio and product performance; the COVID-19 pandemic; the success of our pricing negotiations; current or future macroeconomic trends; and future corporate acquisitions or dispositions.
Risks and uncertainties that may cause actual results to differ materially from forward-looking statements include: challenges and uncertainty resulting from the impact of competition; challenges and uncertainty resulting from the COVID-19 pandemic; our ability to manage our supply chain effectively; supply chain disruptions, cybersecurity risks and other risks arising from the war in
We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as required by applicable law.
Non-GAAP Financial Measures
This press release and the accompanying tables include non-GAAP financial measures, including, among others, adjusted operating income and its related margin, adjusted gross profit and its related margin, adjusted net income, adjusted earnings per diluted share, net sales adjusted for the impact of foreign exchange, acquisitions, divestitures and discontinued brands, adjusted EBITDA and its related margin and operating free cash flow. The reconciliations of these non-GAAP financial measures to the comparable GAAP financial measures are provided herein in the tables. Management believes that the non-GAAP financial measures presented provide useful additional information to investors about current trends in the Company’s operations and are useful for period-over-period comparisons of operations. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read only in connection with the Company’s Consolidated Statements of Operations and Cash Flows presented in accordance with GAAP.
Certain forward-looking non-GAAP financial measures included in this press release are not reconciled to the comparable forward-looking GAAP financial measures. The Company is not able to reconcile these forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures without unreasonable efforts because the Company is unable to predict with a reasonable degree of certainty the type and extent of certain items that would be expected to impact GAAP measures but would not impact the non-GAAP measures. Such items may include litigation and related expenses, transaction costs associated with acquisitions and divestitures, productivity and transformation costs, impairments, gains or losses on sales of assets and businesses, foreign exchange movements and other items. The unavailable information could have a significant impact on the Company’s GAAP financial results.
The Company believes presenting net sales at constant currency provides useful information to investors because it provides transparency to underlying performance in the Company’s consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on period-to-period comparability given the volatility in foreign currency exchange markets. To present this information for historical periods, current period net sales for entities reporting in currencies other than the
The Company provides net sales adjusted for the impact of foreign currency, acquisitions, divestitures and discontinued brands to understand the growth rate of net sales excluding the impact of such items. The Company’s management believes net sales adjusted for such items is useful to investors because it enables them to better understand the growth of our business from period-to-period.
The Company defines adjusted EBITDA as net income before net interest expense, income taxes, depreciation and amortization, equity in net loss (income) of equity-method investees, stock-based compensation, net, unrealized currency gains and losses, litigation and related costs, plant closure related costs, net, productivity and transformation costs, warehouse and manufacturing consolidation and other costs, costs associated with acquisitions, divestitures and other transactions, gains or losses on sales of assets and businesses, inventory write-downs, impairment of long-lived assets and other adjustments. The Company’s management believes that these presentations provide useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses these measures for reviewing the financial results of the Company as well as a component of performance-based executive compensation.
The Company defines operating free cash flow as cash provided by or used in operating activities from continuing operations (a GAAP measure) less purchases of property, plant and equipment. The Company views operating free cash flow as an important measure because it is one factor in evaluating the amount of cash available for discretionary investments.
Consolidated Balance Sheets | |||||||
(unaudited and in thousands) | |||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 57,808 | $ | 75,871 | |||
Accounts receivable, net | 158,734 | 174,066 | |||||
Inventories | 294,428 | 285,410 | |||||
Prepaid expenses and other current assets | 45,308 | 39,834 | |||||
Assets held for sale | 3,313 | 1,874 | |||||
Total current assets | 559,591 | 577,055 | |||||
Property, plant and equipment, net | 312,819 | 312,777 | |||||
950,820 | 871,067 | ||||||
Trademarks and other intangible assets, net | 492,939 | 314,895 | |||||
Investments and joint ventures | 16,056 | 16,917 | |||||
Operating lease right-of-use assets, net | 88,636 | 92,010 | |||||
Other assets | 20,619 | 21,187 | |||||
Total assets | $ | 2,441,480 | $ | 2,205,908 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 176,699 | $ | 171,947 | |||
Accrued expenses and other current liabilities | 98,181 | 117,957 | |||||
Current portion of long-term debt | 7,774 | 530 | |||||
Total current liabilities | 282,654 | 290,434 | |||||
Long-term debt, less current portion | 827,771 | 230,492 | |||||
Deferred income taxes | 86,120 | 42,639 | |||||
Operating lease liabilities, noncurrent portion | 81,379 | 85,929 | |||||
Other noncurrent liabilities | 19,512 | 33,531 | |||||
Total liabilities | 1,297,436 | 683,025 | |||||
Stockholders' equity: | |||||||
Common stock | 1,111 | 1,096 | |||||
Additional paid-in capital | 1,199,804 | 1,187,530 | |||||
Retained earnings | 766,056 | 691,225 | |||||
Accumulated other comprehensive loss | (110,350 | ) | (73,011 | ) | |||
1,856,621 | 1,806,840 | ||||||
Less: |
(712,577 | ) | (283,957 | ) | |||
Total stockholders' equity | 1,144,044 | 1,522,883 | |||||
Total liabilities and stockholders' equity | $ | 2,441,480 | $ | 2,205,908 | |||
Consolidated Statements of Operations | |||||||||||||||
(unaudited and in thousands, except per share amounts) | |||||||||||||||
Third Quarter | Third Quarter Year to Date | ||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
Net sales | $ | 502,939 | $ | 492,604 | $ | 1,434,783 | $ | 1,519,649 | |||||||
Cost of sales | 387,236 | 362,698 | 1,096,367 | 1,140,614 | |||||||||||
Gross profit | 115,703 | 129,906 | 338,416 | 379,035 | |||||||||||
Selling, general and administrative expenses | 75,750 | 74,325 | 229,875 | 238,471 | |||||||||||
Amortization of acquired intangible assets | 3,110 | 2,145 | 7,254 | 6,771 | |||||||||||
Productivity and transformation costs | 1,679 | 4,451 | 8,448 | 10,895 | |||||||||||
Proceeds from insurance claim | - | (592 | ) | (196 | ) | (592 | ) | ||||||||
Long-lived asset and intangibles impairment | - | - | 303 | 57,676 | |||||||||||
Operating income | 35,164 | 49,577 | 92,732 | 65,814 | |||||||||||
Interest and other financing expense, net | 3,224 | 2,030 | 7,672 | 6,820 | |||||||||||
Other (income) expense, net | (712 | ) | 1,566 | (10,570 | ) | (852 | ) | ||||||||
Income from continuing operations before income taxes and equity in net loss (income) of equity-method investees | 32,652 | 45,981 | 95,630 | 59,846 | |||||||||||
Provision for income taxes | 7,738 | 11,797 | 19,425 | 33,197 | |||||||||||
Equity in net loss (income) of equity-method investees | 383 | (70 | ) | 1,374 | 1,025 | ||||||||||
Net income from continuing operations | $ | 24,531 | $ | 34,254 | $ | 74,831 | $ | 25,624 | |||||||
Net income from discontinued operations, net of tax | - | - | - | 11,255 | |||||||||||
Net income | $ | 24,531 | $ | 34,254 | $ | 74,831 | $ | 36,879 | |||||||
Net income per common share: | |||||||||||||||
Basic net income per common share from continuing operations | $ | 0.27 | $ | 0.34 | $ | 0.80 | $ | 0.25 | |||||||
Basic net income per common share from discontinued operations | - | - | - | 0.11 | |||||||||||
Basic net income per common share | $ | 0.27 | $ | 0.34 | $ | 0.80 | $ | 0.36 | |||||||
Diluted net income per common share from continuing operations | $ | 0.27 | $ | 0.34 | $ | 0.79 | $ | 0.25 | |||||||
Diluted net income per common share from discontinued operations | - | - | - | 0.11 | |||||||||||
Diluted net income per common share | $ | 0.27 | $ | 0.34 | $ | 0.79 | $ | 0.36 | |||||||
Shares used in the calculation of net income per common share: | |||||||||||||||
Basic | 91,139 | 99,831 | 94,099 | 100,502 | |||||||||||
Diluted | 91,310 | 101,596 | 94,519 | 101,385 | |||||||||||
Consolidated Statements of Cash Flows | ||||||||||||||||
(unaudited and in thousands) | ||||||||||||||||
Third Quarter | Third Quarter Year to Date | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||||||||||
Net income | $ | 24,531 | $ | 34,254 | $ | 74,831 | $ | 36,879 | ||||||||
Net income from discontinued operations | - | - | - | 11,255 | ||||||||||||
Net income from continuing operations | 24,531 | 34,254 | 74,831 | 25,624 | ||||||||||||
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities from continuing operations: | ||||||||||||||||
Depreciation and amortization | 12,638 | 12,814 | 34,396 | 37,768 | ||||||||||||
Deferred income taxes | 10,645 | 3,124 | 7,374 | 3,216 | ||||||||||||
Equity in net loss (income) of equity-method investees | 383 | (70 | ) | 1,374 | 1,025 | |||||||||||
Stock-based compensation, net | 3,846 | 3,698 | 12,289 | 11,888 | ||||||||||||
Long-lived asset and intangibles impairment | - | - | 303 | 57,676 | ||||||||||||
Loss (gain) on sale of assets | 52 | - | (8,869 | ) | - | |||||||||||
Loss on sale of businesses | - | 1,828 | - | 1,217 | ||||||||||||
Other non-cash items, net | (669 | ) | 431 | (2,155 | ) | (723 | ) | |||||||||
Increase (decrease) in cash attributable to changes in operating assets and liabilities: | ||||||||||||||||
Accounts receivable | 1,780 | (11,198 | ) | 14,150 | (20,721 | ) | ||||||||||
Inventories | (6,844 | ) | (1,792 | ) | (4,371 | ) | (60,304 | ) | ||||||||
Other current assets | (5,870 | ) | 769 | (10,996 | ) | 56,487 | ||||||||||
Other assets and liabilities | (4,481 | ) | 85 | (2,705 | ) | (952 | ) | |||||||||
Accounts payable and accrued expenses | (4,856 | ) | (1,956 | ) | (16,435 | ) | 34,316 | |||||||||
Net cash provided by operating activities from continuing operations | 31,155 | 41,987 | 99,186 | 146,517 | ||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||||||||||
Purchases of property, plant and equipment | (5,943 | ) | (23,391 | ) | (33,939 | ) | (53,062 | ) | ||||||||
Acquisitions of businesses, net of cash acquired | (5,905 | ) | - | (260,474 | ) | - | ||||||||||
Investment in joint venture | (100 | ) | (263 | ) | (614 | ) | (694 | ) | ||||||||
Proceeds from sale of assets | 22 | - | 10,756 | - | ||||||||||||
Proceeds from sale of businesses, net and other | - | 22,930 | - | 27,788 | ||||||||||||
Net cash used in investing activities from continuing operations | (11,926 | ) | (724 | ) | (284,271 | ) | (25,968 | ) | ||||||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||||||||||
Borrowings under bank revolving credit facility | 138,000 | 56,000 | 678,000 | 206,000 | ||||||||||||
Repayments under bank revolving credit facility | (40,000 | ) | (94,000 | ) | (370,000 | ) | (231,000 | ) | ||||||||
Borrowings under term loan | - | - | 300,000 | - | ||||||||||||
Repayments under term loan | (1,875 | ) | - | (1,875 | ) | - | ||||||||||
Payments of other debt, net | (47 | ) | (206 | ) | (3,232 | ) | (1,917 | ) | ||||||||
Share repurchases | (130,472 | ) | (8,562 | ) | (397,405 | ) | (80,298 | ) | ||||||||
Employee shares withheld for taxes | (1,597 | ) | (2,018 | ) | (32,630 | ) | (3,741 | ) | ||||||||
Net cash (used in) provided by financing activities from continuing operations | (35,991 | ) | (48,786 | ) | 172,858 | (110,956 | ) | |||||||||
Effect of exchange rate changes on cash from continuing operations | (2,632 | ) | (84 | ) | (5,836 | ) | 5,650 | |||||||||
Net (decrease) increase in cash and cash equivalents | (19,394 | ) | (7,607 | ) | (18,063 | ) | 15,243 | |||||||||
Cash and cash equivalents at beginning of period | 77,202 | 60,621 | 75,871 | 37,771 | ||||||||||||
Cash and cash equivalents at end of period | $ | 57,808 | $ | 53,014 | $ | 57,808 | $ | 53,014 | ||||||||
(unaudited and in thousands) | |||||||||||||||
International | Corporate/Other | Hain Consolidated | |||||||||||||
Net sales - Q3 FY22 | $ | 325,742 | $ | 177,197 | $ | - | $ | 502,939 | |||||||
Net sales - Q3 FY21 | $ | 287,500 | $ | 205,104 | $ | - | $ | 492,604 | |||||||
% change - FY22 net sales vs. FY21 net sales | 13.3 | % | (13.6 | )% | 2.1 | % | |||||||||
Gross Profit | |||||||||||||||
Q3 FY22 | |||||||||||||||
Gross profit | $ | 75,233 | $ | 40,470 | $ | - | $ | 115,703 | |||||||
Non-GAAP adjustments(1) | 1,836 | 97 | - | 1,933 | |||||||||||
Adjusted gross profit | $ | 77,069 | $ | 40,567 | $ | - | $ | 117,636 | |||||||
Gross margin | 23.1 | % | 22.8 | % | 23.0 | % | |||||||||
Adjusted gross margin | 23.7 | % | 22.9 | % | 23.4 | % | |||||||||
Q3 FY21 | |||||||||||||||
Gross profit | $ | 78,513 | $ | 51,393 | $ | - | $ | 129,906 | |||||||
Non-GAAP adjustments(1) | 3,272 | 1,954 | - | 5,226 | |||||||||||
Adjusted gross profit | $ | 81,785 | $ | 53,347 | $ | - | $ | 135,132 | |||||||
Gross margin | 27.3 | % | 25.1 | % | 26.4 | % | |||||||||
Adjusted gross margin | 28.4 | % | 26.0 | % | 27.4 | % | |||||||||
Operating income (loss) | |||||||||||||||
Q3 FY22 | |||||||||||||||
Operating income (loss) | $ | 28,526 | $ | 18,303 | $ | (11,665 | ) | $ | 35,164 | ||||||
Non-GAAP adjustments(1) | 2,857 | 504 | 3,918 | 7,279 | |||||||||||
Adjusted operating income (loss) | $ | 31,383 | $ | 18,807 | $ | (7,747 | ) | $ | 42,443 | ||||||
Operating income margin | 8.8 | % | 10.3 | % | 7.0 | % | |||||||||
Adjusted operating income margin | 9.6 | % | 10.6 | % | 8.4 | % | |||||||||
Q3 FY21 | |||||||||||||||
Operating income (loss) | $ | 39,492 | $ | 26,774 | $ | (16,689 | ) | $ | 49,577 | ||||||
Non-GAAP adjustments(1) | 4,438 | 2,798 | 2,856 | 10,092 | |||||||||||
Adjusted operating income (loss) | $ | 43,930 | $ | 29,572 | $ | (13,833 | ) | $ | 59,669 | ||||||
Operating income margin | 13.7 | % | 13.1 | % | 10.1 | % | |||||||||
Adjusted operating income margin | 15.3 | % | 14.4 | % | 12.1 | % | |||||||||
(1) See accompanying table "Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Adjusted EPS" | |||||||||||||||
(unaudited and in thousands) | |||||||||||||||
International | Corporate/Other | Hain Consolidated | |||||||||||||
Net sales - Q3 FY22 YTD | $ | 866,281 | $ | 568,502 | $ | - | $ | 1,434,783 | |||||||
Net sales - Q3 FY21 YTD | $ | 850,780 | $ | 668,869 | $ | - | $ | 1,519,649 | |||||||
% change - FY22 net sales vs. FY21 net sales | 1.8 | % | (15.0 | )% | (5.6 | )% | |||||||||
Gross Profit | |||||||||||||||
Q3 FY22 YTD | |||||||||||||||
Gross profit | $ | 199,763 | $ | 138,653 | $ | - | $ | 338,416 | |||||||
Non-GAAP adjustments(1) | 4,429 | 804 | - | 5,233 | |||||||||||
Adjusted gross profit | $ | 204,192 | $ | 139,457 | $ | - | $ | 343,649 | |||||||
Gross margin | 23.1 | % | 24.4 | % | 23.6 | % | |||||||||
Adjusted gross margin | 23.6 | % | 24.5 | % | 24.0 | % | |||||||||
Q3 FY21 YTD | |||||||||||||||
Gross profit | $ | 231,813 | $ | 147,222 | $ | - | $ | 379,035 | |||||||
Non-GAAP adjustments(1) | 6,438 | 3,869 | - | 10,307 | |||||||||||
Adjusted gross profit | $ | 238,251 | $ | 151,091 | $ | - | $ | 389,342 | |||||||
Gross margin | 27.2 | % | 22.0 | % | 24.9 | % | |||||||||
Adjusted gross margin | 28.0 | % | 22.6 | % | 25.6 | % | |||||||||
Operating income (loss) | |||||||||||||||
Q3 FY22 YTD | |||||||||||||||
Operating income (loss) | $ | 72,530 | $ | 69,740 | $ | (49,538 | ) | $ | 92,732 | ||||||
Non-GAAP adjustments(1) | 8,354 | 2,076 | 19,342 | 29,772 | |||||||||||
Adjusted operating income (loss) | $ | 80,884 | $ | 71,816 | $ | (30,196 | ) | $ | 122,504 | ||||||
Operating income margin | 8.4 | % | 12.3 | % | 6.5 | % | |||||||||
Adjusted operating income margin | 9.3 | % | 12.6 | % | 8.5 | % | |||||||||
Q3 FY21 YTD | |||||||||||||||
Operating income (loss) | $ | 105,188 | $ | 8,144 | $ | (47,518 | ) | $ | 65,814 | ||||||
Non-GAAP adjustments(1) | 8,929 | 63,792 | 7,981 | 80,702 | |||||||||||
Adjusted operating income (loss) | $ | 114,117 | $ | 71,936 | $ | (39,537 | ) | $ | 146,516 | ||||||
Operating income margin | 12.4 | % | 1.2 | % | 4.3 | % | |||||||||
Adjusted operating income margin | 13.4 | % | 10.8 | % | 9.6 | % | |||||||||
(1) See accompanying table "Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Adjusted EPS" | |||||||||||||||
Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Adjusted EPS | ||||||||||||||||
(unaudited and in thousands, except per share amounts) | ||||||||||||||||
Third Quarter | ||||||||||||||||
2022 GAAP | Adjustments | 2022 Adjusted | 2021 GAAP | Adjustments | 2021 Adjusted | |||||||||||
Net sales | $ | 502,939 | $ | - | $ | 502,939 | $ | 492,604 | $ | - | $ | 492,604 | ||||
Cost of sales | 387,236 | (1,933 | ) | 385,303 | 362,698 | (5,226 | ) | 357,472 | ||||||||
Gross profit | 115,703 | 1,933 | 117,636 | 129,906 | 5,226 | 135,132 | ||||||||||
Operating expenses(a) | 78,860 | (3,667 | ) | 75,193 | 76,470 | (1,007 | ) | 75,463 | ||||||||
Productivity and transformation costs | 1,679 | (1,679 | ) | - | 4,451 | (4,451 | ) | - | ||||||||
Proceeds from insurance claim | - | - | - | (592 | ) | 592 | - | |||||||||
Operating income | 35,164 | 7,279 | 42,443 | 49,577 | 10,092 | 59,669 | ||||||||||
Interest and other expense (income), net(b) | 2,512 | 539 | 3,051 | 3,596 | (2,346 | ) | 1,250 | |||||||||
Provision for income taxes | 7,738 | 1,533 | 9,271 | 11,797 | 1,950 | 13,747 | ||||||||||
Net income | 24,531 | 5,207 | 29,738 | 34,254 | 10,488 | 44,742 | ||||||||||
Diluted net income per common share | 0.27 | 0.06 | 0.33 | 0.34 | 0.10 | 0.44 | ||||||||||
Detail of Adjustments: | ||||||||||||||||
Q3 FY22 | Q3 FY21 | |||||||||||||||
Plant closure related costs, net | $ | 83 | $ | 1,666 | ||||||||||||
Transaction and integration costs, net | 1,756 | - | ||||||||||||||
Warehouse/manufacturing consolidation and other costs | 94 | 3,560 | ||||||||||||||
Cost of sales | 1,933 | 5,226 | ||||||||||||||
Gross profit | 1,933 | 5,226 | ||||||||||||||
Transaction and integration costs, net | 1,663 | 102 | ||||||||||||||
Litigation expenses | 2,005 | 644 | ||||||||||||||
Plant closure related costs, net | (1 | ) | (2 | ) | ||||||||||||
Warehouse/manufacturing consolidation and other costs | - | 263 | ||||||||||||||
Operating expenses(a) | 3,667 | 1,007 | ||||||||||||||
Productivity and transformation costs | 1,679 | 4,451 | ||||||||||||||
Productivity and transformation costs | 1,679 | 4,451 | ||||||||||||||
Proceeds from insurance claim | - | (592 | ) | |||||||||||||
Proceeds from insurance claim | - | (592 | ) | |||||||||||||
Operating income | 7,279 | 10,092 | ||||||||||||||
Loss on sale of assets | 55 | - | ||||||||||||||
Loss on sale of businesses | - | 1,904 | ||||||||||||||
Unrealized currency (gains) losses | (594 | ) | 442 | |||||||||||||
Interest and other expense (income), net(b) | (539 | ) | 2,346 | |||||||||||||
Income tax related adjustments | (1,533 | ) | (1,950 | ) | ||||||||||||
Provision for income taxes | (1,533 | ) | (1,950 | ) | ||||||||||||
Net income | $ | 5,207 | $ | 10,488 | ||||||||||||
(a) Operating expenses include amortization of acquired intangibles and selling, general and administrative expenses. | ||||||||||||||||
(b) Interest and other expense (income), net includes interest and other financing expenses, net, unrealized currency (gains) losses, loss on sale of assets and businesses and other expense, net. | ||||||||||||||||
Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Adjusted EPS | |||||||||||||||||
(unaudited and in thousands, except per share amounts) | |||||||||||||||||
Third Quarter Year to Date | |||||||||||||||||
2022 GAAP | Adjustments | 2022 Adjusted | 2021 GAAP | Adjustments | 2021 Adjusted | ||||||||||||
Net sales | $ | 1,434,783 | $ | - | $ | 1,434,783 | $ | 1,519,649 | $ | - | $ | 1,519,649 | |||||
Cost of sales | 1,096,367 | (5,233 | ) | 1,091,134 | 1,140,614 | (10,307 | ) | 1,130,307 | |||||||||
Gross profit | 338,416 | 5,233 | 343,649 | 379,035 | 10,307 | 389,342 | |||||||||||
Operating expenses(a) | 237,432 | (16,287 | ) | 221,145 | 302,918 | (60,092 | ) | 242,826 | |||||||||
Productivity and transformation costs | 8,448 | (8,448 | ) | - | 10,895 | (10,895 | ) | - | |||||||||
Proceeds from insurance claim | (196 | ) | 196 | - | (592 | ) | 592 | - | |||||||||
Operating income | 92,732 | 29,772 | 122,504 | 65,814 | 80,702 | 146,516 | |||||||||||
Interest and other (income) expense, net(b) | (2,898 | ) | 11,144 | 8,246 | 5,968 | (758 | ) | 5,210 | |||||||||
Provision for income taxes | 19,425 | 5,553 | 24,978 | 33,197 | 215 | 33,412 | |||||||||||
Net income from continuing operations | 74,831 | 13,075 | 87,906 | 25,624 | 81,245 | 106,869 | |||||||||||
Net income (loss) from discontinued operations, net of tax | - | - | - | 11,255 | (11,255 | ) | - | ||||||||||
Net income | 74,831 | 13,075 | 87,906 | 36,879 | 69,990 | 106,869 | |||||||||||
Diluted net income per common share from continuing operations | 0.79 | 0.14 | 0.93 | 0.25 | 0.80 | 1.05 | |||||||||||
Diluted net income (loss) per common share from discontinued operations | - | - | - | 0.11 | (0.11 | ) | - | ||||||||||
Diluted net income per common share | 0.79 | 0.14 | 0.93 | 0.36 | 0.69 | 1.05 | |||||||||||
Detail of Adjustments: | |||||||||||||||||
Q3 FY22 YTD | Q3 FY21 YTD | ||||||||||||||||
Inventory write-down | $ | (46 | ) | $ | 311 | ||||||||||||
Plant closure related costs, net | 891 | 2,721 | |||||||||||||||
Transaction and integration costs, net | 1,756 | - | |||||||||||||||
Warehouse/manufacturing consolidation and other costs | 2,632 | 7,275 | |||||||||||||||
Cost of sales | 5,233 | 10,307 | |||||||||||||||
Gross profit | 5,233 | 10,307 | |||||||||||||||
Transaction and integration costs, net | 10,395 | 1,476 | |||||||||||||||
Litigation expenses | 5,585 | 644 | |||||||||||||||
Long-lived asset and intangibles impairment | 303 | 57,676 | |||||||||||||||
Plant closure related costs, net | 4 | 33 | |||||||||||||||
Warehouse/manufacturing consolidation and other costs | - | 263 | |||||||||||||||
Operating expenses(a) | 16,287 | 60,092 | |||||||||||||||
Productivity and transformation costs | 8,448 | 10,895 | |||||||||||||||
Productivity and transformation costs | 8,448 | 10,895 | |||||||||||||||
Proceeds from insurance claim | (196 | ) | (592 | ) | |||||||||||||
Proceeds from insurance claim | (196 | ) | (592 | ) | |||||||||||||
Operating income | 29,772 | 80,702 | |||||||||||||||
Gain on sale of assets | (9,047 | ) | - | ||||||||||||||
Loss on sale of businesses | - | 1,293 | |||||||||||||||
Unrealized currency gains | (2,097 | ) | (535 | ) | |||||||||||||
Interest and other (income) expense, net(b) | (11,144 | ) | 758 | ||||||||||||||
Income tax related adjustments | (5,553 | ) | (215 | ) | |||||||||||||
Provision for income taxes | (5,553 | ) | (215 | ) | |||||||||||||
Net income from continuing operations | $ | 13,075 | $ | 81,245 | |||||||||||||
(a) Operating expenses include amortization of acquired intangibles, selling, general and administrative expenses and long-lived asset and intangibles impairment. | |||||||||||||||||
(b) Interest and other (income) expense, net includes interest and other financing expenses, net, unrealized currency gains, (gain) loss on sale of assets and businesses and other expense, net. | |||||||||||||||||
Adjusted Net Sales Growth | ||||||||||||
(unaudited and in thousands) | ||||||||||||
Q3 FY22 | International | Hain Consolidated | ||||||||||
Net sales | $ | 325,742 | $ | 177,197 | $ | 502,939 | ||||||
Acquisitions, divestitures and discontinued brands | (25,232 | ) | - | (25,232 | ) | |||||||
Impact of foreign currency exchange | 30 | 7,301 | 7,331 | |||||||||
Net sales on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands | $ | 300,540 | $ | 184,498 | $ | 485,038 | ||||||
Q3 FY21 | ||||||||||||
Net sales | $ | 287,500 | $ | 205,104 | $ | 492,604 | ||||||
Divestitures and discontinued brands | (10,562 | ) | (4,224 | ) | (14,786 | ) | ||||||
Net sales adjusted for divestitures and discontinued brands | $ | 276,938 | $ | 200,880 | $ | 477,818 | ||||||
Net sales growth (decline) | 13.3 | % | (13.6 | )% | 2.1 | % | ||||||
Impact of acquisitions, divestitures and discontinued brands | (4.8 | )% | 1.8 | % | (2.1 | )% | ||||||
Impact of foreign currency exchange | - | 3.6 | % | 1.5 | % | |||||||
Net sales growth (decline) on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands | 8.5 | % | (8.2 | )% | 1.5 | % | ||||||
Q3 FY22 YTD | International | Hain Consolidated | ||||||||||
Net sales | $ | 866,281 | $ | 568,502 | $ | 1,434,783 | ||||||
Acquisitions, divestitures and discontinued brands | (25,759 | ) | - | (25,759 | ) | |||||||
Impact of foreign currency exchange | (2,697 | ) | (1,067 | ) | (3,764 | ) | ||||||
Net sales on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands | $ | 837,825 | $ | 567,435 | $ | 1,405,260 | ||||||
Q3 FY21 YTD | ||||||||||||
Net sales | $ | 850,780 | $ | 668,869 | $ | 1,519,649 | ||||||
Divestitures and discontinued brands | (34,536 | ) | (75,511 | ) | (110,047 | ) | ||||||
Net sales adjusted for divestitures and discontinued brands | $ | 816,244 | $ | 593,358 | $ | 1,409,602 | ||||||
Net sales growth (decline) | 1.8 | % | (15.0 | )% | (5.6 | )% | ||||||
Impact of acquisitions, divestitures and discontinued brands | 1.1 | % | 10.8 | % | 5.5 | % | ||||||
Impact of foreign currency exchange | (0.3 | )% | (0.2 | )% | (0.2 | )% | ||||||
Net sales growth (decline) on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands | 2.6 | % | (4.4 | )% | (0.3 | )% | ||||||
Adjusted EBITDA | |||||||||||||||
(unaudited and in thousands) | |||||||||||||||
Third Quarter | Third Quarter Year to Date | ||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
Net income | $ | 24,531 | $ | 34,254 | $ | 74,831 | $ | 36,879 | |||||||
Net income from discontinued operations, net of tax | - | - | - | 11,255 | |||||||||||
Net income from continuing operations | $ | 24,531 | $ | 34,254 | $ | 74,831 | $ | 25,624 | |||||||
Depreciation and amortization | 12,638 | 12,814 | 34,396 | 37,768 | |||||||||||
Equity in net loss (income) of equity-method investees | 383 | (70 | ) | 1,374 | 1,025 | ||||||||||
Interest expense, net | 2,846 | 1,327 | 5,677 | 4,781 | |||||||||||
Provision for income taxes | 7,738 | 11,797 | 19,425 | 33,197 | |||||||||||
Stock-based compensation, net | 3,846 | 3,698 | 12,289 | 11,888 | |||||||||||
Unrealized currency (gains) losses | (594 | ) | 442 | (2,097 | ) | (535 | ) | ||||||||
Litigation and related costs | |||||||||||||||
Litigation expenses | 2,005 | 644 | 5,585 | 644 | |||||||||||
Proceeds from insurance claim | - | (592 | ) | (196 | ) | (592 | ) | ||||||||
Restructuring activities | |||||||||||||||
Plant closure related costs, net | 82 | 21 | 895 | 17 | |||||||||||
Productivity and transformation costs | 1,626 | 3,813 | 7,077 | 8,952 | |||||||||||
Warehouse/manufacturing consolidation and other costs | 94 | 3,598 | 2,632 | 7,313 | |||||||||||
Acquisitions, divestitures and other | |||||||||||||||
Transaction and integration costs, net | 3,419 | 102 | 12,151 | 1,476 | |||||||||||
Loss (gain) on sale of assets | 55 | - | (9,047 | ) | - | ||||||||||
Loss on sale of businesses | - | 1,904 | - | 1,293 | |||||||||||
Impairment charges | |||||||||||||||
Inventory write-down | - | - | (46 | ) | 311 | ||||||||||
Long-lived asset and intangibles impairment | - | - | 303 | 57,676 | |||||||||||
Adjusted EBITDA | $ | 58,669 | $ | 73,752 | $ | 165,249 | $ | 190,838 | |||||||
Adjusted EBITDA and Adjusted EBITDA Margin by Segment | |||||||||||||||
(unaudited and in thousands) | |||||||||||||||
Q3 FY22 | International | Corporate/ Other | Hain Consolidated | ||||||||||||
Operating income (loss) | $ | 28,526 | $ | 18,303 | $ | (11,665 | ) | $ | 35,164 | ||||||
Depreciation and amortization | 5,062 | 7,099 | 477 | 12,638 | |||||||||||
Stock-based compensation, net | 921 | 394 | 2,531 | 3,846 | |||||||||||
Transaction and integration costs, net | 1,724 | - | 1,695 | 3,419 | |||||||||||
Litigation expenses | - | - | 2,005 | 2,005 | |||||||||||
Plant closure related costs, net | 79 | 3 | - | 82 | |||||||||||
Productivity and transformation costs | 1,054 | 407 | 165 | 1,626 | |||||||||||
Warehouse/manufacturing consolidation and other costs | - | 94 | - | 94 | |||||||||||
Other | (81 | ) | 169 | (293 | ) | (205 | ) | ||||||||
Adjusted EBITDA | $ | 37,285 | $ | 26,469 | $ | (5,085 | ) | $ | 58,669 | ||||||
Net sales | $ | 325,742 | $ | 177,197 | $ | 502,939 | |||||||||
Adjusted EBITDA margin | 11.4 | % | 14.9 | % | 11.7 | % | |||||||||
Q3 FY21 | International | Corporate/ Other | Hain Consolidated | ||||||||||||
Operating income (loss) | $ | 39,492 | $ | 26,774 | $ | (16,689 | ) | $ | 49,577 | ||||||
Depreciation and amortization | 4,432 | 7,688 | 694 | 12,814 | |||||||||||
Stock-based compensation, net | 849 | 179 | 2,670 | 3,698 | |||||||||||
Transaction and integration costs, net | - | - | 102 | 102 | |||||||||||
Litigation expenses | - | - | 644 | 644 | |||||||||||
Proceeds from insurance claim | - | - | (592 | ) | (592 | ) | |||||||||
Plant closure related costs, net | 21 | - | - | 21 | |||||||||||
Productivity and transformation costs | 1,129 | 621 | 2,063 | 3,813 | |||||||||||
Warehouse/manufacturing consolidation and other costs | 2,591 | 1,007 | - | 3,598 | |||||||||||
Other | (7 | ) | 477 | (393 | ) | 77 | |||||||||
Adjusted EBITDA | $ | 48,507 | $ | 36,746 | $ | (11,501 | ) | $ | 73,752 | ||||||
Net sales | $ | 287,500 | $ | 205,104 | $ | 492,604 | |||||||||
Adjusted EBITDA margin | 16.9 | % | 17.9 | % | 15.0 | % | |||||||||
Adjusted EBITDA and Adjusted EBITDA Margin by Segment | |||||||||||||||
(unaudited and in thousands) | |||||||||||||||
Q3 FY22 YTD | International | Corporate/ Other | Hain Consolidated | ||||||||||||
Operating income (loss) | $ | 72,530 | $ | 69,740 | $ | (49,538 | ) | $ | 92,732 | ||||||
Depreciation and amortization | 12,458 | 19,804 | 2,134 | 34,396 | |||||||||||
Stock-based compensation, net | 2,335 | 1,461 | 8,493 | 12,289 | |||||||||||
Transaction and integration costs, net | 1,426 | - | 10,725 | 12,151 | |||||||||||
Litigation expenses | - | - | 5,585 | 5,585 | |||||||||||
Proceeds from insurance claim | - | - | (196 | ) | (196 | ) | |||||||||
Plant closure related costs, net | 1,197 | (302 | ) | - | 895 | ||||||||||
Productivity and transformation costs | 4,256 | 961 | 1,860 | 7,077 | |||||||||||
Warehouse/manufacturing consolidation and other costs | 1,519 | 1,113 | - | 2,632 | |||||||||||
Inventory write-down | (46 | ) | - | - | (46 | ) | |||||||||
Long-lived asset and intangibles impairment | - | 303 | - | 303 | |||||||||||
Other | (951 | ) | 122 | (1,740 | ) | (2,569 | ) | ||||||||
Adjusted EBITDA | $ | 94,724 | $ | 93,202 | $ | (22,677 | ) | $ | 165,249 | ||||||
Net sales | $ | 866,281 | $ | 568,502 | $ | 1,434,783 | |||||||||
Adjusted EBITDA margin | 10.9 | % | 16.4 | % | 11.5 | % | |||||||||
Q3 FY21 YTD | International | Corporate/ Other | Hain Consolidated | ||||||||||||
Operating income (loss) | $ | 105,188 | $ | 8,144 | $ | (47,518 | ) | $ | 65,814 | ||||||
Depreciation and amortization | 12,693 | 22,969 | 2,106 | 37,768 | |||||||||||
Stock-based compensation, net | 2,568 | 1,223 | 8,097 | 11,888 | |||||||||||
Transaction and integration costs, net | (72 | ) | 86 | 1,462 | 1,476 | ||||||||||
Litigation expenses | - | - | 644 | 644 | |||||||||||
Proceeds from insurance claim | - | - | (592 | ) | (592 | ) | |||||||||
Plant closure related costs, net | (7 | ) | 24 | - | 17 | ||||||||||
Productivity and transformation costs | 2,506 | 3,509 | 2,937 | 8,952 | |||||||||||
Warehouse/manufacturing consolidation and other costs | 4,413 | 2,900 | - | 7,313 | |||||||||||
Inventory write-down | 311 | - | - | 311 | |||||||||||
Long-lived asset and intangibles impairment | (11 | ) | 56,104 | 1,583 | 57,676 | ||||||||||
Other | (361 | ) | 664 | (732 | ) | (429 | ) | ||||||||
Adjusted EBITDA | $ | 127,228 | $ | 95,623 | $ | (32,013 | ) | $ | 190,838 | ||||||
Net sales | $ | 850,780 | $ | 668,869 | $ | 1,519,649 | |||||||||
Adjusted EBITDA margin | 15.0 | % | 14.3 | % | 12.6 | % | |||||||||
Operating Free Cash Flow | |||||||||||||||
(unaudited and in thousands) | |||||||||||||||
Third Quarter | Third Quarter Year to Date | ||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
Net cash provided by operating activities from continuing operations | $ | 31,155 | $ | 41,987 | $ | 99,186 | $ | 146,517 | |||||||
Purchases of property, plant and equipment | (5,943 | ) | (23,391 | ) | (33,939 | ) | (53,062 | ) | |||||||
Operating free cash flow from continuing operations | $ | 25,212 | $ | 18,596 | $ | 65,247 | $ | 93,455 | |||||||
Source: The Hain Celestial Group, Inc.